dr. freedman discusses dual her2-targeted therapy in breast cancer
Published 7 years ago • 62 plays • Length 0:41Download video MP4
Download video MP3
Similar videos
-
0:50
dr. gradishar discusses dual her2-targeting in breast cancer
-
1:02
dr. freedman discusses cns metastases in her2 breast cancer
-
1:07
dr. freedman on preventing brain metastases in her2 breast cancer
-
8:39
breast cancer: dual her2-targeted adjuvant therapy
-
7:41
her2-targeted therapy in early stage her2 breast cancer
-
5:28
her2-targeted therapy in early breast cancer
-
7:44
hormonal and her2-targeted therapy in early breast cancer
-
7:52
introduction and overview of her2-targeted therapies in breast cancer
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
3:45
evolving landscape of her2-targeted therapy in breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
2:01
dr. hurvitz on her2-targeted therapies in breast cancer
-
1:02
dr. freedman on neratinib plus capecitabine for cns disease from her2-positive breast cancer
-
1:37
dr. hurvitz on how to navigate her2-targeted therapy in breast cancer
-
0:55
dr. durand discusses treatment options for toxicities from therapy in her2 breast cancer
-
5:46
use of her2-targeted therapy in breast cancer
-
2:30
dr. pegram on neoadjuvant treatments for her2-postive breast cancer
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
0:59
sequencing her2-targeted therapies in breast cancer